Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hookipa Pharma Inc (NQ: HOOK )

0.8095 -0.0105 (-1.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 136,279
Open 0.8700
Bid (Size) 0.8400 (1)
Ask (Size) 0.8900 (44)
Prev. Close 0.8200
Today's Range 0.8000 - 0.8900
52wk Range 0.7200 - 2.390
Shares Outstanding 21,588,756
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Looking Into HOOKIPA Pharma's Return On Capital Employed
 
Via Benzinga
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga

Performance

YTD
+1.19%
+1.19%
1 Month
-13.00%
-13.00%
3 Month
+3.74%
+3.74%
6 Month
-43.39%
-43.39%
1 Year
-50.03%
-50.03%

More News

Read More
HOOKIPA Pharma's Earnings Outlook
Via Benzinga
Looking Into HOOKIPA Pharma's Return On Capital Employed
Via Benzinga
Short Volatility Alert: HOOKIPA Pharma Inc.
Via Benzinga
HOOKIPA Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook
From HOOKIPA Pharma Inc.
Via Globe NewsWire
HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors
From HOOKIPA Pharma Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
HOOKIPA Pharma to Report Fourth Quarter and Full Year 2022 Financial Results and Provide a Corporate Update on March 15, 2023
From HOOKIPA Pharma Inc.
Via Globe NewsWire
HOOKIPA Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers
From HOOKIPA Pharma Inc.
Via Globe NewsWire
HOOKIPA to Present at the SVB Securities Global Biopharma Conference
From HOOKIPA Pharma Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
HOOKIPA Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine
From HOOKIPA Pharma Inc.
Via Globe NewsWire
HOOKIPA Pharma Appoints Katia Schlienger, M.D., Ph.D., Chief Medical Officer and Malte Peters, M.D., to Board of Directors
From HOOKIPA Pharma Inc.
Via Globe NewsWire
HOOKIPA to Participate in The JMP Securities Hematology and Oncology Summit
From HOOKIPA Pharma Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Advance Auto Parts Shares Are Trading Lower By Around 13%; Here Are 18 Stocks Moving Premarket
Via Benzinga
HOOKIPA Pharma Announces Third Quarter 2022 Financial Results and Provides a Business Update
From HOOKIPA Pharma Inc.
Via Globe NewsWire
Sidoti's November Micro-Cap Virtual Conference
Via ACCESSWIRE
HOOKIPA Pharma to Report Third Quarter 2022 Financial Results and Corporate Updates on November 14, 2022
From HOOKIPA Pharma Inc.
Via Globe NewsWire
HOOKIPA to Participate in the Sidoti Micro-Cap Virtual Conference
From HOOKIPA Pharma Inc.
Via Globe NewsWire
10 Best Medical Stocks Under $5
Via Talk Markets
HOOKIPA Pharma (NASDAQ: HOOK) Enters into Collaboration Deal with Roche to Develop HB-700 For KRAS-Mutated Cancers
Via Spotlight Growth
Why Is Indonesia Energy (INDO) Stock Up Today?
Via InvestorPlace
Why Is Hookipa (HOOK) Stock Up 26% Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.